Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody
Catalog No. TMAB-13257 Copy Product Info
🥰Excellent
Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody is a Rabbit antibody targeting SUCLA2/Renal carcinoma antigen NYREN39. Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody can be used in WB.
Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody
Copy Product Info🥰Excellent
Catalog No. TMAB-13257
Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody is a Rabbit antibody targeting SUCLA2/Renal carcinoma antigen NYREN39. Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody can be used in WB.
Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 50 μL | $221 | 7-10 days | 7-10 days | |
| 100 μL | $372 | 7-10 days | 7-10 days | |
| 200 μL | $528 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Antigen Details
Chemical Properties
Stability & Storage
| Description | Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody is a Rabbit antibody targeting SUCLA2/Renal carcinoma antigen NYREN39. Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody can be used in WB. |
| Ig Type | IgG |
| Reactivity | Human,Mouse (predicted:Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Chimpanzee) |
| Verified Activity | Sample: Hela (Human) Cell Lysate at 30 μg Raw264.7 (Mouse) Cell Lysate at 30 μg Primary: Anti-SUCLA2 (TMAB-13257) at 1/1000 dilution Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution Predicted band size: 45 kD Observed band size: 53 kD |
| Application | |
| Recommended Dose | WB: 1:500-2000 |
| Antibody Type | Polyclonal |
| Host Species | Rabbit |
| Subcellular Localization | Mitochondrion. |
| Tissue Specificity | Widely expressed. |
| Construction | Polyclonal Antibody |
| Purification | Protein A purified |
| Appearance | Liquid |
| Formulation | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Concentration | 1mg/ml |
| Research Background | Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008] |
| Immunogen | KLH conjugated synthetic peptide: human SUCLA2 |
| Antigen Species | Human |
| Gene Name | SUCLA2 |
| Gene ID | |
| Protein Name | Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial |
| Uniprot ID | |
| Function | Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA. |
| Molecular Weight | Theoretical: 45 kDa. |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody | purchase Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody | Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody cost | order Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody | Anti-SUCLA2/Renal carcinoma antigen NYREN39 Polyclonal Antibody molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.